An Abbreviated New Drug Application (ANDA) number is a reference number assigned by the U.S. Food and Drug Administration (FDA) when a manufacturer applies to market a generic version of an approved brand-name drug. The ANDA process confirms that the generic drug is equivalent in dosage, safety, strength, and intended use.